Key result
Worse RV-PA coupling is linked to COVID-19 mortality, with TAPSE/PASP ratios ~0.28 lower in non-survivors.
Why the study?
To assess the association between right ventricular-pulmonary arterial (RV-PA) coupling and mortality in COVID-19.
Is worse right ventricular-pulmonary arterial (RV-PA) coupling associated with increased mortality in adult patients with COVID-19?
Meta-Analysis
Is worse right ventricular-pulmonary arterial (RV-PA) coupling associated with increased mortality in adult patients with COVID-19?
Effect estimate: MD -0.28 (95% CI -0.38, -0.17)
p-value: p=<0.00001
Worse right ventricular-pulmonary arterial coupling, as measured by a lower TAPSE/PASP ratio, is significantly associated with increased mortality in adult patients with COVID-19.
May aid mortality risk stratification in COVID-19; extends meta-analytic evidence on RV-PA coupling as a prognostic marker.
Objectives: In this systematic review and meta-analysis, we assessed the association between right ventricular-pulmonary arterial (RV-PA) coupling and mortality in coronavirus disease 2019 (COVID-19). Methods: We performed a systematic literature search using MEDLINE (PubMed), Embase, Cochrane and Web of Science. We only included observational studies and randomized controlled trials in which, right ventricular function and pulmonary pressures were investigated, in adult patients with COVID-19. The primary outcome was mortality. The secondary outcome was pulmonary embolism (PE). Random-effects meta-analysis was performed. Mean differences (MD) and unadjusted hazard ratios (HRs) were pooled. Results: 21 studies were included in our systematic review for qualitative analysis, and eight of them qualified for quantitative analysis. Tricuspid annular plane systolic excursion (TAPSE) over pulmonary artery systolic pressure (PASP) (TAPSE/PASP) ratio was significantly lower in non-survivors compared with survivors (mean difference = – 0.28 [–0.38, –0.17], p < 0.00001; I2: 61%, p < 0.08). TAPSE was significantly lower in non- survivors compared with survivors (mean difference = – 3.53 [–4.72, –2.33], p < 0.00001; I2: 77%, p < 0.0005). Lower TAPSE was associated with increased mortality (HR = 0.77 [0.63, 0.94], p < 0.010; I2: 77%, p = 0.01). PASP was significantly higher in non-survivors compared with survivors (mean difference = 9.14 [6.67, 11.61], p < 0.00001; I2: 37%, p=0.18). One study demonstrated a higher risk of mortality for lower TAPSE/PASP in both intensive care unit (ICU) and non-ICU patients and, one study showed that TAPSE/PASP was significantly associated with a higher risk of PE. Conclusion: COVID-19 non-survivors have a significantly worse RV-PA coupling as compared to survivors.
No takes yet. Share an insight, caveat, or question.
Vora et al. (2023) conducted a meta-analysis in COVID-19. Right ventricular-pulmonary arterial (RV-PA) coupling assessment (TAPSE/PASP ratio) vs. Survivors was evaluated on Mortality (difference in TAPSE/PASP ratio between non-survivors and survivors) (MD -0.28, 95% CI -0.38, -0.17, p=<0.00001). In patients with COVID-19, non-survivors had significantly worse right ventricular-pulmonary arterial coupling compared to survivors, with a mean difference in TAPSE/PASP ratio of -0.28.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: